We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us


Seegene, Inc. is a developer of multiplex molecular technologies and multiplex clinical molecular diagnostics for inf... read more Featured Products: More products

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

RT-PCR Test Detects Monkeypox Virus Delivers Results in 90 Minutes

By LabMedica International staff writers
Posted on 29 Jun 2022
Print article
Image: Assay targets monkeypox virus and can deliver results in 90 minutes (Photo courtesy of Seegene)
Image: Assay targets monkeypox virus and can deliver results in 90 minutes (Photo courtesy of Seegene)

Monkeypox is an acute zoonotic infection disease caused by the monkeypox virus (MPXV). The disease is mainly transmitted by animals, but it can also be transmitted from person to person through physical contact, body fluids, or even contaminated objects, showing symptoms such as fever, severe headache, and muscle pain. As with many infectious diseases, accurate diagnosis is crucial as treatments are more effective in the early stages of infection. PCR test is known as the gold standard to accurately detect MPXV, so it can be used effectively to prevent the rapid spread of the virus. Timely PCR testing vital, especially for individuals with a suspected case, as the incubation period for the monkeypox infection ranges between five to 21 days. Now, a new real-time PCR assay accurately detects MPXV specifically with a single test and delivers results within 90 minutes.

Seegene, Inc. (Seoul, Korea) has developed a PCR test to detect the MPXV. The Novaplex MPXV Assay, which specifically targets the MPXV, was swiftly developed using the company's AI-based automated test development system, known as SGDDS (Seegene Digitalized Development System), and technologies refined over 20 years of MDx expertise.

According to the World Health Organization, the MPXV is an "evolving health threat that requires collective attention and coordinated action," calling on member states to step up surveillance, contact tracing and testing. The MPXV has been detected in over 50 nations, with South Korea confirming its first case last week. The strain currently circulating in the Northern Hemisphere has an estimated fatality rate of between 3-6% and is considered especially dangerous for children and those with weak immune systems.

Seegene’s Novaplex MPXV Assay can identify positive cases of the MPXV in 90 minutes. The company swiftly developed the product to help curb the worldwide spread. Seegene plans to provide the assay to countries that have detected the virus.

"The monkeypox virus outbreak shows that endemic viruses can rapidly spread to the rest of the world and it's a warning that new pandemics can emerge and threaten our lives at any time," said Dr. Jong-Yoon Chun, CEO of Seegene. "We will continue our efforts to develop products that can accurately diagnose any virus to help prevent new infectious diseases from taking hold and becoming a pandemic."

Related Links:
Seegene, Inc. 

Gold Supplier
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Whole Blood Control
ESR-Chex Plus
STI Test
Rheonix STI TriPlex Assay
Allergen-Specific IgG/IgG4 Enzymimmunoassay
ALLERgen Specific IgG/IgG4 ELISA Kits

Print article
IIR Middle East



view channel
Image: The global infectious disease IVD market is expected to hit USD 57 billion by 2030 (Photo courtesy of Pexels)

Global Infectious Disease IVD Market Dominated by Molecular Diagnostics Technology

The global infectious disease in vitro diagnostics (IVD) market stood at USD 113.7 billion in 2021 and is expected to grow at a CAGR of -7.41% from 2022 to 2030 to hit around USD 56.89 billion by 2030,... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.